Literature DB >> 32445054

MK801-induced locomotor activity in preweanling and adolescent male and female rats: role of the dopamine and serotonin systems.

Sanders A McDougall1, Matthew G Apodaca2, Ginny I Park2, Angie Teran2, Timothy J Baum2, Nazaret R Montejano2.   

Abstract

RATIONALE: MK801, like other NMDA receptor open-channel blockers (e.g., ketamine and phencyclidine), increases the locomotor activity of rats and mice. Whether this behavioral effect ultimately relies on monoamine neurotransmission is of dispute.
OBJECTIVE: The purpose of this study was to determine whether these psychopharmacological effects and underlying neural mechanisms vary according to sex and age.
METHODS: Across four experiments, male and female preweanling and adolescent rats were pretreated with vehicle, the monoamine-depleting agent reserpine (1 or 5 mg/kg), the dopamine (DA) synthesis inhibitor-methyl-DL-p-tyrosine (AMPT), the serotonin (5-HT) synthesis inhibitor 4-chloro-DL-phenylalanine methyl ester hydrochloride (PCPA), or both AMPT and PCPA. The locomotor activity of preweanling and adolescent rats was then measured after saline or MK801 (0.3 mg/kg) treatment.
RESULTS: As expected, MK801 increased the locomotor activity of all age groups and both sexes, but the stimulatory effects were significantly less pronounced in male adolescent rats. Preweanling rats and adolescent female rats were more sensitive to the effects of DA and 5-HT synthesis inhibitors, as AMPT and PCPA caused only small reductions in the MK801-induced locomotor activity of male adolescent rats. Co-administration of AMPT+PCPA or high-dose reserpine (5 mg/kg) treatment substantially reduced MK801-induced locomotor activity in both age groups and across both sexes.
CONCLUSIONS: These results, when combined with other recent studies, show that NMDA receptor open-channel blockers cause pronounced age-dependent behavioral effects that can vary according to sex. The neural changes underlying these sex and age differences appear to involve monoamine neurotransmission.

Entities:  

Keywords:  4-Chloro-DL-phenylalanine methyl ester hydrochloride (PCPA); Locomotor activity; MK801; Ontogeny; Reserpine; ∝-Methyl-DL-p-tyrosine (AMPT)

Mesh:

Substances:

Year:  2020        PMID: 32445054      PMCID: PMC7354898          DOI: 10.1007/s00213-020-05547-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  85 in total

1.  ENHANCEMENT BY RESERPINE AND ALPHA-METHYL DOPA OF THE EFFECTS OF D-AMPHETAMINE UPON THE LOCOMOTOR ACTIVITY OF MICE.

Authors:  C B SMITH
Journal:  J Pharmacol Exp Ther       Date:  1963-12       Impact factor: 4.030

2.  Characteristics of the ambulation-increasing effect of the noncompetitive NMDA antagonist MK-801 in mice: assessment by the coadministration with central-acting drugs.

Authors:  H Kuribara; T Asami; I Ida; S Tadokoro
Journal:  Jpn J Pharmacol       Date:  1992-01

3.  Effects of Mg2+ on recovery of NMDA receptors from inhibition by memantine and ketamine reveal properties of a second site.

Authors:  Nathan G Glasgow; Madeleine R Wilcox; Jon W Johnson
Journal:  Neuropharmacology       Date:  2018-05-12       Impact factor: 5.250

4.  The ontogeny of excitatory amino acid receptors in rat forebrain--I. N-methyl-D-aspartate and quisqualate receptors.

Authors:  T R Insel; L P Miller; R E Gelhard
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

5.  Neurons expressing 5-HT2 receptors in the rat brain: neurochemical identification of cell types by immunocytochemistry.

Authors:  D A Morilak; P Somogyi; R Lujan-Miras; R D Ciaranello
Journal:  Neuropsychopharmacology       Date:  1994-11       Impact factor: 7.853

6.  Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species.

Authors:  R R Holson; B Pearce
Journal:  Neurotoxicol Teratol       Date:  1992 May-Jun       Impact factor: 3.763

7.  A microdialysis study of the medial prefrontal cortex of adolescent and adult rats.

Authors:  Amanda M Staiti; Peter J Morgane; Janina R Galler; Janice Y Grivetti; Donna C Bass; David J Mokler
Journal:  Neuropharmacology       Date:  2011-04-19       Impact factor: 5.250

8.  SCH 23390 equivalently, but YM-09151-2 differentially reduces the stimulant effects of methamphetamine, MK-801 and ketamine: assessment by discrete shuttle avoidance in mice.

Authors:  H Kuribara; Y Uchihashi
Journal:  Jpn J Pharmacol       Date:  1993-05

9.  The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems.

Authors:  W Löscher; D Hönack
Journal:  Eur J Pharmacol       Date:  1992-05-14       Impact factor: 4.432

10.  Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones.

Authors:  J F MacDonald; M C Bartlett; I Mody; P Pahapill; J N Reynolds; M W Salter; J H Schneiderman; P S Pennefather
Journal:  J Physiol       Date:  1991-01       Impact factor: 5.182

View more
  2 in total

1.  Behavioral and Neuroanatomical Consequences of Cell-Type Specific Loss of Dopamine D2 Receptors in the Mouse Cerebral Cortex.

Authors:  Gloria S Lee; Devon L Graham; Brenda L Noble; Taylor S Trammell; Deirdre M McCarthy; Lisa R Anderson; Marcelo Rubinstein; Pradeep G Bhide; Gregg D Stanwood
Journal:  Front Behav Neurosci       Date:  2022-01-13       Impact factor: 3.558

2.  Importance of dopaminergic neurotransmission for the RU 24969-induced locomotor activity of male and female rats during the preweanling period.

Authors:  Sanders A McDougall; Nazaret R Montejano; Ginny I Park; Jasmine A M Robinson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-11-18       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.